NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/03/2026
Voltar para busca
Dado oficial do USPTO
DOSE-2-WEIGHT SYRINGE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
DOSE-2-WEIGHT SYRINGE
ST13
US500000086414662Classe
5
Pedido
86414662
Registro
4871749
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
24/03/2026
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
03/10/2014
Data de registro
15/12/2015
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/03/2026
Última transação
24/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2015-08-00
Primeiro uso no comércio
2015-08-00
Código do desenho
4
Tipo de titular
16
Localização do titular
Bradenton, FL, US
Examinador
DUBRAY, KATHERINE M
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Asepsis Medical Technologies, LLC
Asepsis Medical Technologies, LLC
Representantes
Asepsis Medical Technologies, LLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systemfor the treatment of inflammatory disordersfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes; Vitamin and mineral preparations for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/03/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/03/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
08/12/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
15/12/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
31/08/2022
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
31/08/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
30/08/2022
PUM1
OFFICE ACTION ISSUED POU1
29/03/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/03/2022
ES8R
TEAS SECTION 8 RECEIVED
01/03/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
15/12/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
15/12/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
13/11/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/11/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
20/10/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/10/2015
IUAF
USE AMENDMENT FILED
08/10/2015
EISU
TEAS STATEMENT OF USE RECEIVED
08/10/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22/09/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/07/2015
PUBO
PUBLISHED FOR OPPOSITION
28/07/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/07/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
25/06/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/06/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/06/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/06/2015
ALIE
ASSIGNED TO LIE
08/06/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/05/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/05/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/05/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/01/2015
GNRT
NON-FINAL ACTION E-MAILED
29/01/2015
CNRT
NON-FINAL ACTION WRITTEN
29/01/2015
DOCK
ASSIGNED TO EXAMINER
22/01/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
11/10/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/10/2014
NWAP
NEW APPLICATION ENTERED
07/10/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DOSE-2-WEIGHT SYRINGE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.